These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9747839)

  • 1. A solid water pelvic and prostate phantom for imaging, volume rendering, treatment planning, and dosimetry for an RTOG multi-institutional, 3-D dose escalation study. Radiation Therapy Oncology Group.
    Paliwal BR; Ritter MA; McNutt TR; Mackie TR; Thomadsen BR; Purdy JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):205-11. PubMed ID: 9747839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The design and evaluation of a phantom for the audit of the treatment chain for prostate radiotherapy.
    Perrin BA; Jordan TJ; Hounsell AR
    Radiother Oncol; 2001 Jul; 60(1):37-43. PubMed ID: 11410302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic CT simulation optimization for radiation therapy: A general strategy.
    Li H; Yu L; Anastasio MA; Chen HC; Tan J; Gay H; Michalski JM; Low DA; Mutic S
    Med Phys; 2014 Mar; 41(3):031913. PubMed ID: 24593731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
    Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of a novel MR-compatible pelvic end-to-end phantom.
    Cunningham JM; Barberi EA; Miller J; Kim JP; Glide-Hurst CK
    J Appl Clin Med Phys; 2019 Jan; 20(1):265-275. PubMed ID: 30411477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional clinical trials: 3-D conformal radiotherapy quality assurance. Guidelines in an NCI/RTOG study evaluating dose escalation in prostate cancer radiotherapy.
    Purdy JA; Harms WB; Michalski J; Cox JD
    Front Radiat Ther Oncol; 1996; 29():255-63. PubMed ID: 8742907
    [No Abstract]   [Full Text] [Related]  

  • 7. Technical Note: On the feasibility of performing dosimetry in target and organ at risk using polymer dosimetry gel and thermoluminescence detectors in an anthropomorphic, deformable, and multimodal pelvis phantom.
    Marot M; Elter A; Mann P; Schwahofer A; Lang C; Johnen W; Körber SA; Beuthien-Baumann B; Gillmann C
    Med Phys; 2021 Sep; 48(9):5501-5510. PubMed ID: 34260079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
    Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
    Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pelvic phantom for modeling internal organ motions.
    Kovács P; Sebestyén Z; Farkas R; Bellyei S; Szigeti A; Liposits G; Hideghéty K; Dérczy K; Mangel L
    Med Dosim; 2011; 36(3):250-4. PubMed ID: 20561777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evaluation of low-grade toxicity with conformal radiation therapy for prostate cancer on RTOG 9406 dose levels I and II.
    Michalski JM; Winter K; Purdy JA; Wilder RB; Perez CA; Roach M; Parliament MB; Pollack A; Markoe AM; Harms W; Sandler HM; Cox JD
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):192-8. PubMed ID: 12694838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric intercomparison for two Australasian clinical trials using an anthropomorphic phantom.
    Kron T; Hamilton C; Roff M; Denham J
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):566-79. PubMed ID: 11872306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified intensity-modulated arc therapy for dose escalated prostate cancer radiotherapy.
    Bauman G; Gete E; Chen JZ; Wong E
    Med Dosim; 2004; 29(1):18-25. PubMed ID: 15023389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
    Reft CS; Runkel-Muller R; Myrianthopoulos L
    Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ADAM-pelvis phantom-an anthropomorphic, deformable and multimodal phantom for MRgRT.
    Niebuhr NI; Johnen W; Echner G; Runz A; Bach M; Stoll M; Giske K; Greilich S; Pfaffenberger A
    Phys Med Biol; 2019 Feb; 64(4):04NT05. PubMed ID: 30630152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of using glass-bead thermoluminescent dosimeters for radiotherapy treatment plan verification.
    Jafari SM; Jordan TJ; Distefano G; Bradley DA; Spyrou NM; Nisbet A; Clark CH
    Br J Radiol; 2015; 88(1055):20140804. PubMed ID: 26258442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an in-vivo proton beam range check method in an anthropomorphic pelvic phantom using dose measurements.
    Bentefour el H; Tang S; Cascio EW; Testa M; Samuel D; Prieels D; Gottschalk B; Lu HM
    Med Phys; 2015 Apr; 42(4):1936-47. PubMed ID: 25832084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of In Vivo Volumetric Dosimetry for Prostate Cancer Using Electronic Portal Imaging Device].
    Imae T; Takenaka S; Watanabe Y; Okano Y; Nedu M; Saegusa S; Takeuchi Y; Yano K; Haga A; Shiraishi K; Yamashita H; Nakagawa K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016; 72(11):1128-1136. PubMed ID: 27867173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a dosimetry inter-comparison for IMRT as part of site credentialing for a TROG multi-centre clinical trial for prostate cancer.
    Healy B; Frantzis J; Murry R; Martin J; Middleton M; Catton C; Kron T
    Australas Phys Eng Sci Med; 2011 Jun; 34(2):195-202. PubMed ID: 21424814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.